The API manufacturing site is AstraZeneca’s largest investment into in the state of Virginia to date, and will produce ADCs ...

BMS, which already has two FDA-approved CAR T-cell therapies, is eyeing entry into the growing in vivo market.

Novo Nordisk has agreed to buy Akero Therapeutics in a deal rising to a potential $5.2bn, as the Danish drugmaker looks to ...

Analysts forecast that Boehringer Ingelheim's Jascayd (nerandomalist) will quickly obtain market share from the current SoC ...

Amazon Pharmacy kiosks will stock commonly used drugs such as antibiotics, inhalers, and blood pressure medications.

Celltrion has received approval from the US Food and Drug Administration (FDA) for the biosimilar product, Eydenzelt ...

To address this, many warehouse operations managers are turning to automation, including robotics, to reduce the strain on ...

Peter Marks joins former FDA colleague, Rachael Anatol at Eli Lilly, becoming the second agency worker the pharma has snapped ...

Illuminating its plans, neurological disease specialist MapLight said it would offer 14,750,000 shares of its common stock at ...

Venture financing for messenger ribonucleic acid (mRNA)-based innovator vaccines declined by 82% from $510m in 2023 to $90m ...

The completion of the Series A marks a fast-moving year for Trogenix, which only emerged from stealth in November 2024. The ...

Researchers from McMaster University and MIT have discovered a new antibiotic to treat inflammatory bowel diseases (IBD).